| Literature DB >> 19526073 |
Gunnar Blomquist1, Henry Engler, Agneta Nordberg, Anna Ringheim, Anders Wall, Anton Forsberg, Sergio Estrada, Pernilla Frändberg, Gunnar Antoni, Bengt Långström.
Abstract
The compound {N-methyl-[(11)C]}2-(4'-methylaminophenyl)-6-hydroxybenzothiazole, "PIB", measured by positron emission tomography, has been demonstrated to image brain beta-amyloid deposition in Alzheimer's disease (AD). In the present study the benefit of measuring the PIB accumulation rate together with the unidirectional influx of PIB into the brain was investigated in healthy control subjects and patients with AD. In a monkey changes in the influx rate constant K(1) of PIB closely followed changes in CBF, caused by alteration of Pa(CO2). In addition, K(1) was high both in the monkey and in humans, suggesting that this parameter reflects CBF. Most AD patients studied showed clearly higher accumulation rate for PIB than the controls in cortical brain areas, while a few patients showed as low accumulation as the controls. K(1) did not correlate with the accumulation rate, indicating that K(1) for PIB provides extra information besides the accumulation rate.Entities:
Keywords: Alzheimer´s disease; PET.; beta amyloid; cerebral blood flow; kinetic modeling
Year: 2008 PMID: 19526073 PMCID: PMC2695622 DOI: 10.2174/1874440000802010114
Source DB: PubMed Journal: Open Neuroimag J ISSN: 1874-4400
Clinical data of the subjects in the study classified into different groups as explained in the text. For age and MMSE, mean value, standard deviation and range are presented. The different groups are defined in the text. MMSE = mini-mental state examination
| Groups | No. of Subjects | Age at Study Mean (SD) Range | Arterial Sampling | MMSE at Study Mean (SD) Range |
|---|---|---|---|---|
| HC-young | 3 | 21 (0) | 2 | 30 |
| HC-old | 5 | 67 (7) | 1 | 30 |
| HC-Hi | 1 | 77 | 1 | 30 |
| Hi | 1 | 71 | 1 | 30 |
| AD-Lo | 4 | 72 (11) | 3 | 28.3 (0.5) |
| AD-Hi | 17 | 65 (9) | 5 | 22.7 (4.7) |
The accumulation rate constant Kacc from the irreversible 2-compartment model “input-3k” and the unidirectional influx rate constant K1 from the reversible 2-comartment model “input-4k” in selected regions. Means and SDs are presented. The different groups are defined in the text. The standardized difference is described in the text
| Region | Used CBV | Kacc (min-1) from irreversible 2-compartment model (input-3k) | K1 (min-1) from reversible 2-compartment model (input-4k) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HC ( | HC-Hi ( | Hi (n=1) | AD-Lo ( | AD-Hi ( | Stand diff AD-Hi-HC | HC (n=3) | HC-Hi (n=1) | Hi (n=1) | AD-Lo (n=3) | AD-Hi (n=5) | Stand. Diff.AD-Hi- HC | ||
| Whole brain | 0.035 | 0.0175 | 0.0185 | 0.0274 | 0.0156 | 0.0326 | 3.55 | 0.28 | 0.18 | 0.20 | 0.18 | 0.18 | -2.34 |
| PrVisual cortex | 0.05 | 0.0127 | 0.0152 | 0.0223 | 0.0124 | 0.0359 | 3.65 | 0.38 | 0.23 | 0.28 | 0.24 | 0.27 | -2.15 |
| Frontal cortex | 0.05 | 0.0136 | 0.0221 | 0.0367 | 0.0145 | 0.0389 | 5.19 | 0.31 | 0.19 | 0.23 | 0.19 | 0.20 | -2.26 |
| Parietal cortex | 0.05 | 0.0148 | 0.0212 | 0.0313 | 0.0148 | 0.0369 | 5.04 | 0.32 | 0.20 | 0.20 | 0.19 | 0.16 | -3.46 |
| Temporal cortex | 0.05 | 0.0140 | 0.0151 | 0.0235 | 0.0132 | 0.0306 | 4.19 | 0.27 | 0.17 | 0.17 | 0.15 | 0.15 | -2.93 |
| Putamen | 0.04 | 0.0119 | 0.0148 | 0.0293 | 0.0149 | 0.0358 | 7.80 | 0.40 | 0.27 | 0.30 | 0.26 | 0.30 | -2.56 |
| Thalamus | 0.04 | 0.0132 | 0.0137 | 0.0274 | 0.0112 | 0.0243 | 2.56 | 0.35 | 0.25 | 0.30 | 0.25 | 0.30 | -0.68 |
| Pons | 0.02 | 0.0186 | 0.0159 | 0.0250 | 0.0197 | 0.0246 | 1.03 | 0.32 | 0.19 | 0.23 | 0.19 | 0.29 | -0.26 |
| White matter | 0.02 | 0.0250 | 0.0225 | 0.0179 | 0.0219 | 0.0312 | 1.56 | 0.17 | 0.13 | 0.07 | 0.09 | 0.10 | -2.03 |
| Cerebellar cortex | 0.05 | 0.0137 | 0.0086 | 0.0110 | 0.0107 | 0.0169 | 0.69 | 0.38 | 0.25 | 0.32 | 0.22 | 0.24 | -4.79 |
Ratio between average uptakes in the target region and cerebellar cortex using data in the time interval 40–60 min (late uptake ratio). The groups are defined in the text. Only patients with arterial sampling are included. Means and SDs of the samples are presented. The standardized difference is described in the text
| region | Cobs(target)/Cobs(cereb) averaged over the interval [40–60min] | |||||
|---|---|---|---|---|---|---|
| HC ( | HC-Hi ( | Hi (n=1) | AD-Lo ( | AD-Hi (n=5) | Stand diff (AD-Hi – HC) | |
| Whole brain | 1.27 | 1.52 | 1.74 | 1.16 | 1.68 | 1.96 |
| PrVisual cortex | 1.06 | 1.32 | 1.47 | 1.01 | 1.78 | 2.42 |
| Frontal cortex | 1.05 | 1.75 | 2.26 | 1.11 | 2.02 | 3.75 |
| Parietal cortex | 1.14 | 1.72 | 1.94 | 1.15 | 1.93 | 4.35 |
| Temporal cortex | 1.13 | 1.40 | 1.59 | 1.09 | 1.64 | 3.06 |
| Putamen | 1.08 | 1.43 | 1.94 | 1.27 | 1.90 | 3.92 |
| Thalamus | 1.30 | 1.38 | 2.14 | 1.26 | 1.53 | 0.91 |
| Pons | 1.63 | 1.54 | 1.52 | 1.68 | 1.53 | -0.87 |
| White matter | 1.62 | 1.81 | 1.73 | 1.44 | 1.63 | 0.05 |
Results from the monkey experiment. Base: baseline experiment, CO2: experiment with increased CBF caused by increased PaCO2 with the aid of respiratory control. The models applied are described in the text
| Region | CBF (ml g-1 min-1) | K1 input-3k (ml g-1 min-1) | Kacc input-3k (min-1) | k3 input-3k (min-1) | Late uptake ratio | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Base C | O2 Ba | se | CO2 Ba | se | CO2 Ba | se | CO2 Ba | se | CO2 | |
| Cerebellar cortex | 0.029 | 0.034 | 0.013 | 0.012 | 1.00 | 1.00 | ||||
| Frontal cortex | 0.30 | 0.46 | 0.24 | 0.37 | 0.021 | 0.027 | 0.012 | 0.014 | 0.77 | 0.84 |
| Occipital cortex | 0.026 | 0.034 | 0.012 | 0.013 | 0.94 | 1.03 | ||||
| Thalamus | 0.28 | 0.54 | 0.18 | 0.35 | 0.026 | 0.032 | 0.008 | 0.008 | 1.29 | 1.21 |